Clinical Trials Browser

Has results × Urinary Bladder Neoplasms × Vorinostat × Clear all

NCT02619253 2024-11-18

Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma

Phase 1 Completed

52 enrolled 17 charts

Urinary Bladder Neoplasms, Carcinoma, Renal Cell